Caldan Therapeutics Limited
- Company number
- SC515558
- Status
- Dissolved
- Type
- Private Limited Company
- Incorporated
- 14 Sep 2015
- Dissolved
- 30 Jul 2026
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (51123 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GOUGH, Lori Krim, Dr | Director | 15 Nov 2023 | |
| CANNING, Mary Eugenie, Dr | Director | 22 Apr 2021 | |
| PAYTON, Mark Anthony, Dr | Director | 31 Jul 2019 | |
| MILLIGAN, Graeme | Director | 14 Sep 2015 | |
| ULVEN, Trond | Director | 14 Sep 2015 | |
| STEINHAGEN, Henning Klaus-Willi Christian, Dr | Director | 31 Jul 2019 | 15 Nov 2023 |
| DUGDALE-BRADLEY, Linda Anne, Dr | Director | 22 Apr 2021 | 31 Aug 2023 |
| ARMSTRONG, Frank, Dr | Director | 8 Mar 2016 | 31 May 2022 |
| ROPER, Elizabeth Ann, Dr | Director | 9 Oct 2015 | 22 Apr 2021 |
| DALRYMPLE, Michael Alexander, Doctor | Director | 19 Jun 2019 | 29 Mar 2021 |
| FINAN, Peter Michael, Dr | Director | 9 Nov 2015 | 31 Jul 2019 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Epidarex Capital Ii Lp | Ownership Of Shares 25 To 50 Percent As Firm Voting Rights 25 To 50 Percent As Firm |
6 Apr 2016 | |
| Epidarex Capital Partners Limited | Ownership Of Shares 25 To 50 Percent | 6 Apr 2016 | 6 Apr 2016 |
| Scottish Enterprise | Ownership Of Shares 25 To 50 Percent As Firm | 6 Apr 2016 | 6 Apr 2016 |
Accounts
Connections
Owned by
Caldan Therapeutics Limited → Epidarex Capital Ii, LP → ELI Lilly And Company Limited → ELI Lilly Group Limited
Directors’ other companies
- MILLIGAN, Graeme - Director at Keltic Pharma Limited